• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[使用68Ga-DOTATATE PET/CT对神经内分泌肿瘤中生长抑素受体的免疫组化表达进行定量分析]

[Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT].

作者信息

Haug A R, Assmann G, Rist C, Tiling R, Schmidt G P, Bartenstein P, Hacker M

机构信息

Klinik und Poliklinik für Nuklearmedizin, Klinikum der Ludwigs-Maximilians-Universität München, Campus Grosshadern, Marchioninistr. 15, 81377, München, Deutschland.

出版信息

Radiologe. 2010 Apr;50(4):349-54. doi: 10.1007/s00117-009-1972-2.

DOI:10.1007/s00117-009-1972-2
PMID:20333502
Abstract

PURPOSE

The immunohistochemical expression of somatostatin receptor (SSTR) subtype 2 was compared to quantitative (68)Ga-DOTATATE PET in neuroendocrine tumors (NET).

MATERIAL AND METHODS

In 27 patients suffering from metastatic NET the expression of somatostatin receptors (SSTR, score 0-3) and the Ki-67 index were assessed. The immunohistochemical findings were compared with the (68)Ga-DOTATATE PET uptake in these tumors using the SUV(max) (standardized uptake value). Both values were compared with the Ki-67 proliferation index.

RESULTS

The SUV(max) in NET without SSTR expression was significantly lower compared to those with SSTR expression (p <0.05), even though 3 out of 5 NETs with a score of 0 showed a high uptake of (68)Ga-DOTATATE. The SUV(max) correlated significantly (r=0.40, p <0.05) with the score of immunohistochemical SSTR expression (negative, score 0, moderate, score 1 and high, scores 2 and 3). The Ki-67 index correlated inversely with the SSTR expression score (r=-0.42, p <0.05), but not significantly with the SUV(max) (r=-0.33, p=0.11).

CONCLUSION

(68)Ga-DOTATATE uptake was moderately correlated with the results of immunohistochemical SSTR analyses. However, SSTR negative NET may show high uptake of (68)Ga-DOTATATE.

摘要

目的

比较生长抑素受体(SSTR)2型在神经内分泌肿瘤(NET)中的免疫组化表达与定量(68)Ga-DOTATATE PET检查结果。

材料与方法

对27例转移性NET患者评估生长抑素受体的表达(SSTR,评分0 - 3)和Ki-67指数。将免疫组化结果与这些肿瘤的(68)Ga-DOTATATE PET摄取情况(使用SUV(max),即标准化摄取值)进行比较。将这两个值与Ki-67增殖指数进行比较。

结果

与有SSTR表达的NET相比,无SSTR表达的NET的SUV(max)显著更低(p <0.05),尽管5例评分为0的NET中有3例显示(68)Ga-DOTATATE摄取较高。SUV(max)与免疫组化SSTR表达评分(阴性,评分为0;中度,评分为1;高,评分为2和3)显著相关(r = 0.40,p <0.05)。Ki-67指数与SSTR表达评分呈负相关(r = -0.42,p <0.05),但与SUV(max)无显著相关性(r = -0.33,p = 0.11)。

结论

(68)Ga-DOTATATE摄取与免疫组化SSTR分析结果呈中度相关。然而,SSTR阴性的NET可能显示出较高的(68)Ga-DOTATATE摄取。

相似文献

1
[Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT].[使用68Ga-DOTATATE PET/CT对神经内分泌肿瘤中生长抑素受体的免疫组化表达进行定量分析]
Radiologe. 2010 Apr;50(4):349-54. doi: 10.1007/s00117-009-1972-2.
2
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.68Ga-DOTATOC与68Ga-DOTATATE的患者体内定量和定性比较:用于准确量化的净摄取率
J Nucl Med. 2014 Feb;55(2):204-10. doi: 10.2967/jnumed.113.126177. Epub 2013 Dec 30.
3
Parametric Net Influx Rate Images of Ga-DOTATOC and Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast.镓-多柔比星和镓-多他拉嗪的参数化净流入率图像:定量准确性和改进的图像对比度
J Nucl Med. 2017 May;58(5):744-749. doi: 10.2967/jnumed.116.180380. Epub 2016 Oct 27.
4
A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.68Ga-DOTATATE与18F-FDG PET/CT在肺神经内分泌肿瘤中的比较
J Nucl Med. 2009 Dec;50(12):1927-32. doi: 10.2967/jnumed.109.066639. Epub 2009 Nov 12.
5
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤患者中 68Ga-DOTANOC 与 68Ga-DOTATATE PET/CT 的比较。
J Nucl Med. 2013 Mar;54(3):364-72. doi: 10.2967/jnumed.112.111724. Epub 2013 Jan 7.
6
The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors.在进展性转移性神经内分泌肿瘤患者中,68Ga-DOTATATE PET 摄取与 177Lu-DOTATATE 治疗的形态学反应之间的关联。
Nucl Med Commun. 2022 Jan 1;43(1):73-77. doi: 10.1097/MNM.0000000000001488.
7
Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on Ga-DOTATATE PET/MR.基于 Ga-DOTATATE PET/MR 对神经内分泌肿瘤患者 SSTR-RADS-3A 和 SSTR-RADS-3B 病变的预后预测。
J Cancer Res Clin Oncol. 2024 May 25;150(5):272. doi: 10.1007/s00432-024-05776-5.
8
MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Ga-DOTATATE and F-FDG and Multimodality Anatomic Imaging in Metastatic Neuroendocrine Tumors of Unknown Primary in a PRRT Workup Setting.在肽受体放射性核素治疗(PRRT)检查背景下,对镓-多柔比星(Ga-DOTATATE)和氟-氟代脱氧葡萄糖(F-FDG)双示踪剂PET/CT及多模态解剖成像进行MIB-1指数分层评估,用于不明原发灶的转移性神经内分泌肿瘤。
J Nucl Med Technol. 2017 Mar;45(1):34-41. doi: 10.2967/jnmt.116.185777. Epub 2017 Feb 2.
9
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.生长抑素受体 PET 在神经内分泌肿瘤中的应用:68Ga-DOTA0,Tyr3-奥曲肽与 68Ga-DOTA0-兰瑞肽的比较。
Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):364-72. doi: 10.1007/s00259-012-2286-6. Epub 2012 Nov 14.
10
Gallium-68-dotatate PET/CT is better than CT in the management of somatostatin expressing tumors: First experience in Africa.镓-68-奥曲肽PET/CT在生长抑素表达肿瘤的管理中优于CT:非洲的首次经验。
Hell J Nucl Med. 2017 May-Aug;20(2):128-133. doi: 10.1967/s002449910553. Epub 2017 Jul 12.

引用本文的文献

1
In Vivo Versus In Vitro Somatostatin Receptor Expression in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Correlation Studies.神经内分泌肿瘤体内与体外生长抑素受体表达:相关性研究的系统评价与Meta分析
Int J Mol Sci. 2025 Jul 8;26(14):6551. doi: 10.3390/ijms26146551.
2
Correlation of Somatostatin Receptor 1-5 Expression, [Ga]Ga-DOTANOC, [F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms.前瞻性胰腺神经内分泌肿瘤队列中生长抑素受体1 - 5表达、[镓]镓 - DOTANOC、[氟]氟 - FDG PET/CT与临床结局的相关性
Cancers (Basel). 2021 Dec 29;14(1):162. doi: 10.3390/cancers14010162.
3

本文引用的文献

1
Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.多期 68Ga-DOTATOC-PET/CT 对神经内分泌肿瘤患者治疗管理的影响。
Neuroendocrinology. 2010;91(1):101-9. doi: 10.1159/000265561. Epub 2009 Dec 9.
2
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.18F-氟-L-多巴、18F-氟脱氧葡萄糖和 18F-氟多巴 PET 与 123I-MIBG 闪烁显像在嗜铬细胞瘤和副神经节瘤定位中的比较。
J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67. doi: 10.1210/jc.2009-1248. Epub 2009 Oct 28.
3
The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors.
[68Ga]镓-多胺基多乙酸-酪胺酸([68Ga]Ga-DOTA-TATE)正电子发射断层显像/X线计算机体层成像(PET/CT)在疑似垂体肿瘤诊断及管理中的价值
Eur J Hybrid Imaging. 2021 May 24;5(1):10. doi: 10.1186/s41824-021-00104-3.
4
Prospective study of dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition in patients with well-differentiated neuroendocrine tumors.前瞻性研究在分化良好的神经内分泌肿瘤患者中进行动态全身 68Ga-DOTATOC-PET/CT 采集。
Sci Rep. 2021 Mar 1;11(1):4727. doi: 10.1038/s41598-021-83965-9.
5
[Early endocrine neoplasia of the pancreas].[胰腺早期内分泌肿瘤]
Chirurg. 2018 Apr;89(4):266-273. doi: 10.1007/s00104-017-0546-5.
6
Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.68Ga-DOTANOC 全身PET/MRI与68Ga-DOTANOC PET/CT在神经内分泌肿瘤患者中的比较:28例患者的前瞻性研究
Clin Nucl Med. 2017 Sep;42(9):669-674. doi: 10.1097/RLU.0000000000001753.
7
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.生长抑素与CXCR4趋化因子受体在不同恶性程度的胃肠胰神经内分泌肿瘤中的反向表达
Oncotarget. 2015 Sep 29;6(29):27566-79. doi: 10.18632/oncotarget.4491.
8
[Gastroenteropancreatic endocrine tumors].[胃肠胰内分泌肿瘤]
Radiologe. 2014 Oct;54(10):989-97. doi: 10.1007/s00117-014-2689-4.
9
Somatostatin receptor immunohistochemistry in neuroendocrine tumors: comparison between manual and automated evaluation.神经内分泌肿瘤中生长抑素受体免疫组织化学:手动评估与自动评估的比较
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4971-80. eCollection 2014.
10
Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas.腹部 MRI 联合弥散加权成像与 68Ga-DOTATATE PET/CT 对胰腺神经内分泌肿瘤的检测比较。
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):897-907. doi: 10.1007/s00259-013-2371-5. Epub 2013 Mar 5.
[Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations].
[68Ga-DOTATOC PET/CT检查期间患者的辐射暴露]
Nuklearmedizin. 2009;48(5):201-7. doi: 10.3413/nukmed-0214. Epub 2009 Jul 28.
4
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.使用 (68)Ga-DOTA-NOC 受体 PET/CT 检测未知原发神经内分泌肿瘤(CUP-NET)。
Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):67-77. doi: 10.1007/s00259-009-1205-y.
5
Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.18F-FDG PET和生长抑素受体闪烁扫描术对转移性内分泌肿瘤患者的预测价值
J Nucl Med. 2009 Jun;50(6):858-64. doi: 10.2967/jnumed.108.057505. Epub 2009 May 14.
6
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.68Ga-DOTA-TATE与18F-DOPA PET在高分化转移性神经内分泌肿瘤患者中的个体内比较。
Eur J Nucl Med Mol Imaging. 2009 May;36(5):765-70. doi: 10.1007/s00259-008-1030-8. Epub 2009 Jan 10.
7
Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT.生长抑素受体2免疫组织病理学表达与68Ga-DOTATOC PET/CT标准化摄取值的相关性
Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):48-52. doi: 10.1007/s00259-008-0944-5. Epub 2008 Sep 20.
8
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.“类癌”百年之后:美国35825例神经内分泌肿瘤的流行病学及预后因素
J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377.
9
Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.使用68Ga-DOTATATE(DOTA-DPhe1,Tyr3-奥曲肽)和18F-FDG联合PET/CT对神经内分泌肿瘤进行功能成像。
Cancer. 2008 Jun;112(11):2447-55. doi: 10.1002/cncr.23469.
10
Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.铟-111-奥曲肽闪烁扫描术与生长抑素受体2型表达:高分化恶性内分泌肿瘤的新预后因素
J Clin Oncol. 2008 Feb 20;26(6):963-70. doi: 10.1200/JCO.2007.12.7431.